Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.53 |
| ▸ | HTR3B | O95264 | 1/20 | 0.53 |
| ▸ | HTR3A | P46098 | 1/20 | 0.53 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.53 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 3/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29541540 | 1.00 | HTR3E (0.53) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL8943270 | 0.87 | CYP3A4 (0.50) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL8103653 | 0.87 | TDP1 (0.65) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL29808710 | 0.84 | TDP1 (0.44) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL5104173 | 0.84 | TDP1 (0.44) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL10810705 | 0.83 | TAAR1 (0.47) | TAAR1SIGMAR1MAPK1 | |
| SCHEMBL7133728 | 0.82 | CYP3A4 (0.44) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL8675079 | 0.82 | ACHE (0.45) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL17707284 | 0.81 | HTR3E (0.62) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL10818541 | 0.81 | HTR3E (0.62) | HTR3EHTR3BHTR3AHTR3DHTR3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1777 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119161580-A | Amide group-containing polydisulfide degradable high polymer material and preparation method thereof | 衢州化工新材料创新研究院 | 2024-12-20 | — | — | CN | claimed |
| US-20230151136-A1 | CATALYST COMPOSITION FOR POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | claimed |
| US-20230134280-A1 | CATALYSTS FOR THE FORMATION OF POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-04 | — | — | US | claimed |
| EP-4114877-A1 | CATALYSTS FOR THE FORMATION OF POLYURETHANES | Momentive Performance Materials Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| EP-4114566-A1 | CATALYST COMPOSITION FOR POLYURETHANES | Momentive Performance Materials Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| CN-115243789-A | Catalyst composition for polyurethane | 迈图高新材料公司 | 2022-10-25 | — | — | CN | claimed |
| CN-115210283-A | Catalysts for polyurethane formation | 迈图高新材料公司 | 2022-10-18 | — | — | CN | claimed |
| CN-114276303-A | Ureido compound or its medicinal salt and its preparing process and application | 河南大学 | 2022-04-05 | — | — | CN | claimed |
| US-20210332211-A1 | CATALYSTS FOR PRODUCING POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2021-10-28 | — | — | US | claimed |
| CN-112791511-A | Oriented porous structure material for filtration and preparation method thereof | 扬州大学 | 2021-05-14 | — | — | CN | claimed |
| US-20040215038-A1 | Colorant precursor compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215002-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215022-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040214918-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-6790267-B1 | METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS | XEROX CORPORATION | 2004-09-14 | — | — | US | claimed |
| US-20040167249-A1 | Phase change inks with isocyanate-derived antioxidants and UV stabilizers | XEROX CORPORATION | 2004-08-26 | — | — | US | claimed |
| US-6764541-B1 | Colorant compositions | XEROX CORPORATION | 2004-07-20 | — | — | US | claimed |
| US-6652635-B2 | Cyan phase change inks | XEROX CORPORATION | 2003-11-25 | — | — | US | claimed |
| US-20030079645-A1 | Cyan phase change inks | XEROX CORPORATION | 2003-05-01 | — | — | US | claimed |
| US-5229243-A | Addition polymer core, polyurethane or polythiourethane shell | KAO CORPORATION (JP) | 1993-07-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040215022-A1 | Colorant compositions | ARSA, TST, IK | HTR3E 3030/4885HTR3B 2965/4885HTR3A 2548/4885 |
| US-20040215038-A1 | Colorant precursor compositions | RB1, SULT1A1, CBR1 | HTR3E 3396/4885HTR3B 2825/4885HTR3A 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.